BlackRock Advisors’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-40,277
Closed -$82K 3874
2016
Q1
$82K Buy
40,277
+6,667
+20% +$11.9K ﹤0.01% 3010
2015
Q4
$83K Sell
33,610
-17,866
-35% -$53K ﹤0.01% 3003
2015
Q3
$134K Sell
51,476
-1,174
-2% -$3.06K ﹤0.01% 2957
2015
Q2
$165K Buy
52,650
+7,968
+18% +$27.3K ﹤0.01% 2909
2015
Q1
$128K Buy
44,682
+6,422
+17% +$16.4K ﹤0.01% 2923
2014
Q4
$99K Sell
38,260
-259,324
-87% -$1.13M ﹤0.01% 3051
2014
Q3
$2.22M Sell
297,584
-409,888
-58% -$3.83M ﹤0.01% 1144
2014
Q2
$8.33M Buy
707,472
+154,420
+28% +$1.65M 0.01% 835
2014
Q1
$6.42M Buy
553,052
+451,052
+442% +$5.31M 0.01% 915
2013
Q4
$1.11M Buy
102,000
+3,361
+3% +$33.1K ﹤0.01% 1449
2013
Q3
$1.06M Buy
98,639
+70,668
+253% +$805K ﹤0.01% 1398
2013
Q2
$328K Buy
+27,971
New +$279K ﹤0.01% 2143

BlackRock Advisors's SZYM Position: Q2 2016 in Review

BlackRock Advisors sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 40,277 shares — an estimated $82K sold.

BlackRock Advisors first reported a position in SZYM in Q2 2013 and held it in 12 quarters. The position peaked at $8.33M in Q2 2014. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.

  • BlackRock Advisors reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
  • BlackRock Advisors sold 40,277 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $82K.
  • BlackRock Advisors first reported a position in SOLAZYME INC COM STK (DE) in Q2 2013 and held it in 12 quarters.
  • BlackRock Advisors's SOLAZYME INC COM STK (DE) position peaked at $8.33M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.

Based on BlackRock Advisors's 13F filing for Q2 2016, filed 10 Aug 2016.